BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 30972640)

  • 1. Long-Term Safety and Efficacy of Fecal Microbiota Transplant in Active Ulcerative Colitis.
    Ding X; Li Q; Li P; Zhang T; Cui B; Ji G; Lu X; Zhang F
    Drug Saf; 2019 Jul; 42(7):869-880. PubMed ID: 30972640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy and safety of monotherapy with a single fresh fecal microbiota transplant for recurrent active ulcerative colitis: a prospective randomized pilot study.
    Fang H; Fu L; Li X; Lu C; Su Y; Xiong K; Zhang L
    Microb Cell Fact; 2021 Jan; 20(1):18. PubMed ID: 33468164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial.
    Paramsothy S; Kamm MA; Kaakoush NO; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Paramsothy R; Xuan W; Lin E; Mitchell HM; Borody TJ
    Lancet; 2017 Mar; 389(10075):1218-1228. PubMed ID: 28214091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Step-up fecal microbiota transplantation strategy: a pilot study for steroid-dependent ulcerative colitis.
    Cui B; Li P; Xu L; Zhao Y; Wang H; Peng Z; Xu H; Xiang J; He Z; Zhang T; Nie Y; Wu K; Fan D; Ji G; Zhang F
    J Transl Med; 2015 Sep; 13():298. PubMed ID: 26363929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the efficacy and safety of fecal microbiota transplantation and probiotic VSL#3 for active ulcerative colitis: A systematic review and meta-analysis.
    Dang X; Xu M; Liu D; Zhou D; Yang W
    PLoS One; 2020; 15(3):e0228846. PubMed ID: 32182248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.
    Jacob V; Crawford C; Cohen-Mekelburg S; Viladomiu M; Putzel GG; Schneider Y; Chabouni F; OʼNeil S; Bosworth B; Woo V; Ajami NJ; Petrosino JF; Gerardin Y; Kassam Z; Smith M; Iliev ID; Sonnenberg GF; Artis D; Scherl E; Longman RS
    Inflamm Bowel Dis; 2017 Jun; 23(6):903-911. PubMed ID: 28445246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal Microbiota Transplantation for Ulcerative Colitis: The Optimum Timing and Gut Microbiota as Predictors for Long-Term Clinical Outcomes.
    Li Q; Ding X; Liu K; Marcella C; Liu X; Zhang T; Liu Y; Li P; Xiang L; Cui B; Wang J; Bai J; Zhang F
    Clin Transl Gastroenterol; 2020 Aug; 11(8):e00224. PubMed ID: 32955197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal microbiota transplantation for ulcerative colitis: a prospective clinical study.
    Tian Y; Zhou Y; Huang S; Li J; Zhao K; Li X; Wen X; Li XA
    BMC Gastroenterol; 2019 Jul; 19(1):116. PubMed ID: 31272391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of single fecal microbiota transplantation for Japanese patients with mild to moderately active ulcerative colitis.
    Nishida A; Imaeda H; Ohno M; Inatomi O; Bamba S; Sugimoto M; Andoh A
    J Gastroenterol; 2017 Apr; 52(4):476-482. PubMed ID: 27730312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Fecal Microbiota Transplantation in the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials.
    El Hage Chehade N; Ghoneim S; Shah S; Chahine A; Mourad FH; Francis FF; Binion DG; Farraye FA; Hashash JG
    Inflamm Bowel Dis; 2023 May; 29(5):808-817. PubMed ID: 35766805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Older patients benefit more from sequential courses of washed microbiota transplantation than younger population with ulcerative colitis.
    Liu Y; Ji X; Huang Y; Li Q; Ding X; Wang Y; Zhang S; Wen Q; Cui B; Lu X; Zhang F
    Scand J Gastroenterol; 2023; 58(8):890-899. PubMed ID: 36864569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refractory ulcerative colitis stabilized by interval washed microbiota transplantation: less is more.
    Wang Y; Cui B; Zhang F
    Curr Med Res Opin; 2022 Apr; 38(4):531-534. PubMed ID: 35040380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial.
    Costello SP; Hughes PA; Waters O; Bryant RV; Vincent AD; Blatchford P; Katsikeros R; Makanyanga J; Campaniello MA; Mavrangelos C; Rosewarne CP; Bickley C; Peters C; Schoeman MN; Conlon MA; Roberts-Thomson IC; Andrews JM
    JAMA; 2019 Jan; 321(2):156-164. PubMed ID: 30644982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis.
    Rossen NG; Fuentes S; van der Spek MJ; Tijssen JG; Hartman JH; Duflou A; Löwenberg M; van den Brink GR; Mathus-Vliegen EM; de Vos WM; Zoetendal EG; D'Haens GR; Ponsioen CY
    Gastroenterology; 2015 Jul; 149(1):110-118.e4. PubMed ID: 25836986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of fecal microbiota transplantation by washed preparation in patients with moderate to severely active ulcerative colitis.
    Chen M; Liu XL; Zhang YJ; Nie YZ; Wu KC; Shi YQ
    J Dig Dis; 2020 Nov; 21(11):621-628. PubMed ID: 32909356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Siderophore-harboring gut bacteria and fecal siderophore genes for predicting the responsiveness of fecal microbiota transplantation for active ulcerative colitis.
    Yan J; Zhou G; Ren R; Zhang X; Zhang N; Wang Z; Peng L; Yang Y
    J Transl Med; 2024 Jun; 22(1):589. PubMed ID: 38915068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pectin enhances the effect of fecal microbiota transplantation in ulcerative colitis by delaying the loss of diversity of gut flora.
    Wei Y; Gong J; Zhu W; Tian H; Ding C; Gu L; Li N; Li J
    BMC Microbiol; 2016 Nov; 16(1):255. PubMed ID: 27809778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis.
    Kump P; Wurm P; Gröchenig HP; Wenzl H; Petritsch W; Halwachs B; Wagner M; Stadlbauer V; Eherer A; Hoffmann KM; Deutschmann A; Reicht G; Reiter L; Slawitsch P; Gorkiewicz G; Högenauer C
    Aliment Pharmacol Ther; 2018 Jan; 47(1):67-77. PubMed ID: 29052237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fecal microbiota transplantation for the treatment of ulcerative colitis: a Meta-analysis].
    Mo R; Ren RR; Zhang XW; Yang YS
    Zhonghua Nei Ke Za Zhi; 2019 Mar; 58(3):202-208. PubMed ID: 30803179
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhancing patient adherence to fecal microbiota transplantation maintains the long-term clinical effects in ulcerative colitis.
    Li Q; Zhang T; Ding X; Xiang L; Cui B; Buch H; Zhang F
    Eur J Gastroenterol Hepatol; 2020 Aug; 32(8):955-962. PubMed ID: 32282545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.